greeksoup/ stock research

Healthstream (HSTM) FY2023 results: revenue $279 million, up 4.6% on the year

Healthstream Inc. (HSTM) reported revenue of $279 million for fiscal 2023, the year ended 31 December 2023, up 4.6% on the year before. Net income was $15 million, up 25.8%, and diluted earnings per share $0.50. The figures are the company's own, from the 10-K it filed with the SEC on 26 February 2024.

Revenue
$279 million
+4.6% on the year
FY2016FY2023
Operating margin
5.7%
4.7% a year earlier
FY2016FY2023
Net income
$15 million
+25.8% on the year
FY2016FY2023
Diluted EPS
$0.50
+28.2% on the year
FY2016FY2023

this yearthe year beforeHover a bar for its figure.

The year in brief

The four quarters: Q1 FY2023 · Q2 FY2023 · Q3 FY2023 · Q4 FY2023

Income statement (profit and loss)

$ millionFY2023FY2022FY2021On the yearLast 8 years
Revenue279267257+4.6%
Cost of revenue95.091.191.0+4.3%
Gross profit184176166+4.8%
Gross margin65.9%65.8%64.5%
Research and development45.544.341.7+2.9%
Operating income16.012.48.1+28.7%
Operating margin5.7%4.7%3.1%
Pre-tax income18.515.67.8+18.8%
Income tax3.33.51.9-5.6%
Effective tax rate17.8%22.4%24.7%
Net income15.212.15.8+25.8%
Net margin5.5%4.5%2.3%
Diluted EPS$0.50$0.39$0.18+28.2%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2023FY2022FY2021On the yearLast 8 years
Operating cash flow64.051.242.4+25.0%
Capital expenditure2.21.83.4+24.4%
Free cash flow61.849.439.0+25.0%
Free cash flow margin22.1%18.5%15.2%
Cash from investing-56.6-28.4-25.7
Cash from financing-13.0-23.7-6.2
Depreciation and amortisation41.137.936.8+8.3%
Share-based compensation4.23.65.3+16.9%
Buybacks8.923.15.0-61.4%
Dividends paid3.10.00.0
Dividend per share$0.10$0.00$0.00
Diluted shares, weighted31m31m32m-0.1%
Shares outstanding at period end30m31m31m-0.9%

Balance sheet

$ millionFY2023FY2022FY2021On the yearLast 8 years
Shareholders' equity341334339+2.0%
Debt0.00.00.0
Operating lease liabilities20.223.326.2-13.2%
Other liabilities139140122-1.0%
Total liabilities and equity500498487+0.4%
Fixed assets13.015.517.9-16.0%
Goodwill191192183-0.5%
Intangible assets68.081.689.2-16.6%
Investments30.87.95.0+290.6%
Cash and equivalents40.346.046.9-12.4%
Receivables34.336.730.3-6.5%
Other assets122118115+3.7%
Total assets500498487+0.4%

10-K for the year ended 31 December 2023, filed 26 February 2024: the filing.